Andrew D. Walker

Partner

Emailandrew.d.walker@dlapiper.com

About

Andrew Walker is a business-minded strategic advisor who focuses his practice primarily on representing private equity sponsors and their portfolio companies in complex business transactions, including mergers and acquisitions, divestitures, the creation of new business platforms, and serving as outside general counsel.

Andrew and his wife, Aubrey, reside in the Austin area with their four kids and two dogs.

Areas of FocusMergers and Acquisitions Private Equity Corporate

Bar admissionsTexas

EXPERIENCE

Represented private equity sponsor and its portfolio company in a 50/50 recapitalization with another private equity sponsor
Represented private equity sponsor in its 50/50 partnership with another private equity sponsor to acquire a business
Represented private equity sponsor in its acquisition of a medication intelligence company
Represented private equity sponsor in its acquisition of a drug diversion monitoring company
Represented private equity sponsor in its acquisition of an industry-leading provider of commercial real estate and real estate investment trust data and analytics, research, news, and advisory and consulting services
Represented private equity sponsor in its acquisition of a music company powered by innovative technology that was created as an alternative to the traditional music business model
Represented portfolio company in its sale of a division to another portfolio company
Represented portfolio company in its acquisition of a leading provider of modern endpoint management solutions
Represented private equity sponsor in its acquisition of a leading provider of healthcare clearinghouse and software solutions
Represented a joint venture portfolio company in its acquisition of a leading provider of risk adjustment healthcare solutions
Represented private equity sponsor in its acquisition of a market-leading private company intelligence platform for the financial services industry from another private equity sponsor
Represented private equity sponsor in its sale of an MSP and technology provider to another company
Represented portfolio company in its acquisition of an Apple device management company
Represented a joint venture portfolio company in its acquisition of an information technology company that provides risk and quality solutions to healthcare payers and providers
Represented private equity sponsor in its acquisition of a leading provider of IT asset management software for small and medium-sized businesses
Represented private equity sponsor in the sale of its minority interest in a global supplier of plasmid DNA for commercial, clinical, and research-stage cell and gene therapies, to another company